ArticleRespirology case reports2025
Shrinking Lung Syndrome as an Early Manifestation of Systemic Lupus Erythematosus: A Case Report With Literature Review.
Article in Respirology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Suspected shrinking lung syndrome: a rare pulmonary manifestation of systemic lupus erythematosus-a case-based review of an underrecognized condition.Rheumatology international · 2026Review
- Improved Lung Function With Cyclophosphamide and Rituximab in a Case of Shrinking Lung Syndrome.Cureus · 2025Article
- Shrinking Lung Syndrome as an Early Manifestation of Systemic Lupus Erythematosus: A Case Report With Literature Review.Respirology case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Systemic lupus erythematosus (SLE) can involve the respiratory system through various manifestations, including the rare pulmonary complication known as shrinking lung syndrome (SLS). SLS is characterised by progressive dyspnoea, pleuritic chest pain, diaphragmatic elevation, reduced lung volumes, a restrictive pattern on pulmonary function tests, and decreased diffusing capacity for carbon monoxide. Diagnosing SLS is challenging, as it requires ruling out interstitial lung disease and significant pleural pathology. While the onset of SLS varies, it typically occurs around 4 years after SLE diagnosis. Here, we report the case of a 33-year-old woman with SLE who developed SLS as an unusual early manifestation of the disease. SLS should be considered in the differential diagnosis of respiratory symptoms in patients with suspected or confirmed SLE, even in its early stages. Early recognition and appropriate management are essential for optimising outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.